Skip to main content

Hedge fund manager guilty of $7m insider-trading scheme

Joseph Contorinis used inside information about mergers and acquisitions to execute trades

handcuffs

NEW YORK – Former hedge fund manager Joseph Contorinis, has been found guilty on eight counts of fraud in an insider-trading case in New York City.

Over a two-year period from 2004 to 2006, Contorinis received information from Nicos Stephanou, a UBS investment banker, based in New York and London, on mergers and acquisitions. Contorinis then used that information to execute trades, accruing, according to prosecutors, up to $7 million in profits, despite knowing that Stephanou was violating confidentiality agreements with both his employer and clients.

Stephanou previously pleaded guilty and agreed to act as the government's chief witness in the trial. Contorinis could face up to 20 years in prison on each of the most serious charges and millions of dollars in fines, and is due to be sentenced on February 4, 2011.

Preet Bahara, US Attorney for the Southern district of New York, said the verdict "sends yet another strong message of deterrence to anyone who is thinking about gaming the system like Joseph Contorinis did". Bahara also thanked the FBI and SEC for their assistance in the multi-lateral investigation of Contorinis' case.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Emerging trends in op risk

Karen Man, partner and member of the global financial institutions leadership team at Baker McKenzie, discusses emerging op risks in the wake of the Covid‑19 pandemic, a rise in cyber attacks, concerns around conduct and culture, and the complexities of…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here